Hypoxia-inducible factor-1 and oncogenic signalling

被引:163
|
作者
Bárdos, JI [1 ]
Athcroft, M [1 ]
机构
[1] Inst Canc Res, Ctr Canc Therapeut, Cell Growth Regulat & Angiogenesis Lab, Sutton SM2 5NG, Surrey, England
关键词
D O I
10.1002/bies.20002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of underlying mechanisms Involved in the activation of HIF-1 in response to both hypoxic stress and oncogenic signals has important implications for how these processes may become deregulated in human dancer. Changes in microenvironmental stimuli such as hypoxia and growth factors in combination With genetic lesions such as loss or inactivation of p53, PTEN or pVHL or oncogenic activation, can all lead to increased HIF-1 activity This provides cancer cells With a distinct ad Vantage for survival and proliferation, resulting in their ability to form vascular tumours, which are aggressive and metastatic. Accordingly, upregulation of HIF-1alpha, a key component of HIF-1, correlates with a poor treatment outcome Using conventional therapies. A Variety of mechanisms exist that regulate expression of HIF-lalpha. In recent years, it has become clear that an extensive network of signalling cascades converge on HIF-1alpha to regulate the transcriptional response. A better understanding of this regulation may provide 6 basis for the development of new cancer therapies. BioEssays 26:M 269, 2004. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 50 条
  • [21] Hypoxia-inducible factor-1 as a therapeutic target in cancer
    Tang, Ceen-Ming
    Yu, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 401 - 405
  • [22] Hypoxia-inducible factor-1 regulation and therapeutic implication
    Rustum, Youcef M.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S9 - S9
  • [23] Tetrathiomolybdate mediates the degradation of hypoxia-inducible factor-1α
    Kim, Kyu Kwang
    Abelman, Sarah
    Yano, Naohiro
    Ribeiro, Jennifer R.
    Singh, Rakesh K.
    Tipping, Marla
    Moore, Richard G.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (03) : 590 - 590
  • [24] Living kidney donors and hypoxia-inducible factor-1α
    Baan, C
    van Gelder, T
    Peeters, A
    Mol, W
    Niesters, H
    Weimar, W
    IJzermans, J
    TRANSPLANTATION, 2003, 75 (04) : 570 - 571
  • [25] Hypoxia-inducible factor-1 regulation of myeloid cells
    Stothers, C. L.
    Luan, L.
    Fensterheim, B. A.
    Bohannon, J. K.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (12): : 1293 - 1306
  • [26] The Role of Hypoxia-inducible Factor-1 in Bladder Cancer
    Chai, Jiagui
    Yin, Sifan
    Feng, Wenbo
    Zhang, Tao
    Ke, Changxing
    CURRENT MOLECULAR MEDICINE, 2024, 24 (07) : 827 - 834
  • [27] Targeting hypoxia-inducible factor-1 for therapy and prevention
    Zhong, H
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) : 951 - 966
  • [28] A role for hypoxia-inducible factor-1α in desferoxamine neuroprotection
    Hamrick, SEG
    McQuillen, PS
    Jiang, XN
    Mu, DZ
    Madan, A
    Ferriero, DM
    NEUROSCIENCE LETTERS, 2005, 379 (02) : 96 - 100
  • [29] Hypoxia-Inducible Factor-1α and Autoimmune Lupus, Arthritis
    Zu-Cheng Yang
    Yi Liu
    Inflammation, 2016, 39 : 1268 - 1273
  • [30] The Role of Hypoxia-Inducible Factor-1α in Acetaminophen Hepatotoxicity
    Sparkenbaugh, Erica M.
    Saini, Yogesh
    Greenwood, Krista K.
    LaPres, John J.
    Luyendyk, James P.
    Copple, Bryan L.
    Maddox, Jane F.
    Ganey, Patricia E.
    Roth, Robert A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (02): : 492 - 502